Relative Value Partners Group’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $228K | Buy |
+2,454
| New | +$228K | 0.03% | 292 |
|
|
2022
Q1 | – | Sell |
-1,831
| Closed | -$205K | – | 259 |
|
|
2021
Q4 | $205K | Hold |
1,831
| – | – | 0.01% | 178 |
|
|
2021
Q3 | $230K | Hold |
1,831
| – | – | 0.02% | 176 |
|
|
2021
Q2 | $248K | Hold |
1,831
| – | – | 0.02% | 169 |
|
|
2021
Q1 | $248K | Sell |
1,831
-418
| -19% | -$56.6K | 0.02% | 184 |
|
|
2020
Q4 | $317K | Sell |
2,249
-40
| -2% | -$5.64K | 0.03% | 164 |
|
|
2020
Q3 | $255K | Hold |
2,289
| – | – | 0.03% | 157 |
|
|
2020
Q2 | $256K | Buy |
+2,289
| New | +$256K | 0.03% | 152 |
|